Bladder Urothelial Carcinoma

Showing 1 - 24 of 24

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bladder Urothelial Carcinoma, Bladder Cancer Trial in São Paulo (Monopolar Transurethral resection of bladder tumor, Holmium

Recruiting
  • Bladder Urothelial Carcinoma
  • Bladder Cancer
  • Monopolar Transurethral resection of bladder tumor
  • Holmium Laser resection of bladder tumor (HoLEBT)
  • São Paulo, Brazil
    Instituto do Cancer do Estado de São Paulo (ICESP)
Apr 18, 2023

NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +13 more
  • (no location specified)
Mar 29, 2023

Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8 Trial in United States (drug,

Recruiting
  • Bladder Urothelial Carcinoma
  • +3 more
  • Phoenix, Arizona
  • +320 more
Feb 2, 2023

Bladder Urothelial Carcinoma, Stage III Bladder Cancer AJCC v8 Trial in United States (drug, biological, other, radiation)

Recruiting
  • Bladder Urothelial Carcinoma
  • Stage III Bladder Cancer AJCC v8
  • Anchorage, Alaska
  • +212 more
Jan 31, 2023

Bladder Urothelial Carcinoma, Urothelial Carcinoma Trial in Philadelphia (Copper Cu 64 TP3805, Positron Emission Tomography,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • Urothelial Carcinoma
  • Copper Cu 64 TP3805
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Dec 13, 2022

Bladder Urothelial Carcinoma Trial in Nanjing (primary focal resection plus lymph node dissection, Tislelizumab, Gemcitabine

Recruiting
  • Bladder Urothelial Carcinoma
  • primary focal resection plus lymph node dissection
  • +2 more
  • Nanjing, Jiangsu, China
    The first affiliated hospital of Nanjing Medical University
Dec 7, 2022

Bladder Carcinoma, Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma Trial in Toronto (biological, procedure,

Recruiting
  • Bladder Carcinoma
  • +7 more
  • Atezolizumab
  • +5 more
  • Toronto, Ontario, Canada
    University Health Network Princess Margaret Cancer Center LAO
Nov 8, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)

Terminated
  • Bladder Cancer
  • Bladder Urothelial Carcinoma
  • re-TURBT
  • 6 weeks BCG instillation
  • Toronto, Ontario, Canada
    University Health Network
Apr 12, 2022

Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Squamous Cell Carcinoma Trial in Palo Alto (drug, procedure,

Active, not recruiting
  • Bladder Adenocarcinoma
  • +11 more
  • Palo Alto, California
    Stanford Cancer Institute Palo Alto
Mar 25, 2022

Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

Recruiting
  • Sarcoma, Synovial
  • +8 more
  • CYCLOPHOSPHAMIDE and FLUDARABIN
  • +3 more
  • Jerusalem, Israel
    Hadassah Medical Organization
Mar 15, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Bladder Urothelial Carcinoma Trial in Tianjin (Live Combined (Bifidobacterium,Lactobacillus and Enterococcus Capsules))

Recruiting
  • Bladder Urothelial Carcinoma
  • Live Combined (Bifidobacterium,Lactobacillus and Enterococcus Capsules)
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Feb 1, 2022

Bladder Urothelial Carcinoma, Stage IV Bladder Cancer AJCC v8, Stage IVA Bladder Cancer AJCC v8 Trial in Los Angeles

Active, not recruiting
  • Bladder Urothelial Carcinoma
  • +3 more
  • Durvalumab
  • +2 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Dec 2, 2021

Patients With FGFR-Mutant Bladder Cancer Receiving Erdafitinib

Recruiting
  • Bladder Cancer
  • +12 more
  • Raleigh, North Carolina
    xCures Virtual Site
Sep 20, 2021

Bladder Cancer, Bladder Tumor, Bladder Urothelial Carcinoma Trial in Fuenlabrada (En bloc TURBT Collins Loop, Conventional

Recruiting
  • Bladder Cancer
  • +4 more
  • En bloc TURBT Collins Loop
  • Conventional TURBT
  • Fuenlabrada, Madrid, Spain
    Hospital Universitario de Fuenlabrada
Aug 24, 2021

Urothelial Carcinoma, Head Neck Cancer, Melanoma Trial in Canada, Spain, United States (Autologous genetically modified MAGE

Completed
  • Urothelial Carcinoma
  • +3 more
  • Autologous genetically modified MAGE A10ᶜ⁷⁹⁶T cells
  • Boston, Massachusetts
  • +10 more
Dec 17, 2020

MRI Contrast Media Adverse Reaction, Bladder Cancer, Bladder Disease Trial in Mansoura (Multi-parametric MRI)

Unknown status
  • MRI Contrast Media Adverse Reaction
  • +6 more
  • Multi-parametric MRI
  • Mansoura, Aldakahlia, Egypt
    Urology and Nephrology Center
Nov 20, 2019

Bladder Cancer, Bladder Urothelial Carcinoma, Trauma Trial in Mansoura (Computed tomographic cystography)

Unknown status
  • Bladder Cancer
  • +7 more
  • Computed tomographic cystography
  • Mansoura, Aldakahlia, Egypt
    Urology and Nephrology Center
Oct 15, 2019

Bladder Urothelial Carcinoma, TURBT, Bladder Tumor Trial in Mansoura (SPIES assisted TURBT, WLI assisted TURBT)

Unknown status
  • Bladder Urothelial Carcinoma
  • +3 more
  • SPIES assisted TURBT
  • WLI assisted TURBT
  • Mansoura, Aldakahlia, Egypt
    Urology and Nephrology Center
May 19, 2017

Bladder Adenocarcinoma, Bladder Squamous Cell Carcinoma, Bladder Urothelial Carcinoma Trial in New Brunswick (biological,

Terminated
  • Bladder Adenocarcinoma
  • +7 more
  • Recombinant Fowlpox-TRICOM Vaccine
  • +4 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Dec 22, 2014

Bladder Urothelial Carcinoma Trial in Taipei

Unknown status
  • Bladder Urothelial Carcinoma
    • Taipei, Taiwan
      Department of Urology, National Taiwan University Hospital
    Oct 24, 2013